Skip to main content
Log in

NICE draft guidance: apremilast not recommended

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. tumour necrosis factor-α

Reference

  • NICE. NICE issues draft guidance on apremilast for psoriatic arthritis. Media Release : 3 Sep 2015. Available from: URL: http://www.nice.org.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

NICE draft guidance: apremilast not recommended. PharmacoEcon Outcomes News 736, 31 (2015). https://doi.org/10.1007/s40274-015-2441-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2441-y

Navigation